|
||||||||||||||||||||||||||
|
Most companies want to be and claim to be on the right side of the fine line that demarcates ethical CI from low life espionage. Only, different people and companies draw lines at different places. Let’s first distinguish between personal and corporate ethical lines. My friend works with the competition. Is it OK if he talks A recent Investment Confidence Index survey report, released by JP Morgan and ValueNotes, brings out an interesting finding. According to the survey, Indian investors are wary of the climate change and perceive it as a negative indicator for the Indian economy. The findings reveal that nearly 15% retail investors[1] consider climate change as an Recently while doing a study to gauge the investment attractiveness of certain Indian states for a global auto manufacturing company I realized that the biggest hurdle was that most of these states were facing a severe energy deficit. In fact India has a power deficit of around 10 to 17% where, a third All competitors have access to the similar data and information. But only a few of them are able to leverage it to ink success stories. While data constitutes fragments of information that are unconnected to each other or the environment, information is the knowledge build by putting several data points together. Intelligence is understanding the implication When India based biotechnology firm Biocon entered into an agreement with Pfizer recently, a lot of hype was generated on biosimilars being the next big cash cow for India. Biocon struck this deal to introduce biosimilar insulin products in India – the second diabetes capital in the world after China. Biosimilars[1] are generic impersonation of biotech |
|
|||||||||||||||||||||||||
|
Copyright © 2012 ValueNotes Database Pvt. Ltd.|All Rights Reserved|Terms of Use |
||||||||||||||||||||||||||
Recent Comments